Search results
14 Unhealthiest Pancake Toppings You Should Avoid
Mashed via Yahoo News· 7 days agoEveryone loves pancakes for breakfast, but adding sugary toppings that have additives can be unhealthy. Take a look at the least healthy toppings for...
Around 42 Percent Of Those Aged 20 And Above In The US Are Obese, Yet GLP-1 Weight Loss Drugs Are...
Wccftech· 2 days agoWall Street is convinced that anti-obesity GLP-1 drugs constitute a thematic bull case, with Goldman...
Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure,...
Digital Journal· 2 days agoRenova is exploring new therapeutic opportunities that have the potential to expand the use of Renova's gene therapy platform to include several pathologies associated with diabetes and heart ...
Two-Drug Treatment Could Curb Meth Addiction
Fox Bangor· 4 days agoThough overdose deaths continue to surge, there is no approved medication to treat methamphetamine use disorder. Now, an experimental two-drug therapy...
New therapeutic targets to fight type 2 diabetes
Medical Xpress· 7 days agoIt also helps to identify new drug targets in the fight against type 2 diabetes mellitus, which the World Health Organization (WHO) considers one of the pandemics of the 21st century. The study ...
I'm an ICU doctor. When I needed a liver transplant I learned how vulnerable it is to be a patient.
Business Insider· 3 days agoDonald Chalfin's wife made him take a blood test after he showed symptoms of being sick. He needed a...
Akero Therapeutics, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy...
Morningstar· 3 days agoThe Portnoy Law Firm advises Akero Therapeutics, Inc. ("Akero" or the “Company”) (NASDAQ: AKRO) investors that a class action has been filed on behalf of investors. Akero investors that lost ...
6 Natural Sugar Options for Enjoying Sweet Summer Treats
CNET· 6 days agoIf you’ve got adventures planned this summer, the last thing you want to worry about is monitoring...
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update
ETF DAILY NEWS· 23 hours agoENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 277,600 ...
Ascendiant Capital Markets Lowers ENDRA Life Sciences (NASDAQ:NDRA) Price Target to $8.00
ETF DAILY NEWS· 5 days agoENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) had its price objective lowered by stock analysts at Ascendiant Capital Markets from $10.00 to $8.00 in a research report issued to clients ...
